Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lotus Eye Hospital & InstituteBOM:532998 72 Cyclically Adjusted PS Ratio is 4.60 as of Aug. 24, 2026, which is 51% above its 10-year median of 3.05. GuruFocus rates BOM:532998 with a GF Score™ of 72/100 and a GF Value™ of ₹98.25 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 360 Healthcare Providers & Services companies, Lotus Eye Hospital & Institute ranks worse than 85.56% on this metric.
The historical rank and industry rank for Lotus Eye Hospital & Institute's Cyclically Adjusted PS Ratio or its related term are showing as below:
BOM:532998'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.43 Med: 3.05 Max: 5.49
Current: 4.6
During the past years, Lotus Eye Hospital & Institute's highest Cyclically Adjusted PS Ratio was 5.49. The lowest was 1.43. And the median was 3.05.
BOM:532998's Cyclically Adjusted PS Ratio is ranked worse than 85.56% of 360
companies
in the Healthcare Providers & Services industry
Industry Median: 1.195
vs BOM:532998: 4.60
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Lotus Eye Hospital & Institute's adjusted revenue per share data for the three months ended in Jun. 2026 was ₹8.338. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₹25.31 for the trailing ten years ended in Jun. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
Lotus Eye Hospital & Institute (BOM:532998) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Lotus Eye Hospital & Institute Cyclically Adjusted PS Ratio Related Terms
Lotus Eye Hospital & Institute Cyclically Adjusted PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lotus Eye Hospital & Institute Cyclically Adjusted PS Ratio Chart
BOM:532998 vs HCA, THC, DVA: Cyclically Adjusted PS Ratio Comparison
For the Medical Care Facilities subindustry, Lotus Eye Hospital & Institute's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lotus Eye Hospital & Institute Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Lotus Eye Hospital & Institute's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Lotus Eye Hospital & Institute's Cyclically Adjusted PS Ratio falls into.
Lotus Eye Hospital & Institute Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 4.60 mean?
Lotus Eye Hospital & Institute (BOM:532998) has a Cyclically Adjusted PS Ratio of 4.60 as of Aug. 24, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Lotus Eye Hospital & Institute and its competitors. This is 51% above median its historical median of 3.05. Over the past decade, Lotus Eye Hospital & Institute's Cyclically Adjusted PS Ratio has ranged from 1.43 to 5.49. According to the industry distribution chart, Lotus Eye Hospital & Institute ranks #308 out of 360 companies in the Healthcare Providers & Services industry, placing it in the top 85.6%.
Is Lotus Eye Hospital & Institute's Cyclically Adjusted PS Ratio too high?
Lotus Eye Hospital & Institute's current Cyclically Adjusted PS Ratio of 4.60 is 51% above median its 10-year median of 3.05. Over the past 10 years, this metric has ranged from a low of 1.43 to a high of 5.49. The Healthcare Providers & Services industry median Cyclically Adjusted PS Ratio is 1.20. Lotus Eye Hospital & Institute's value of 4.60 is 284.9% above this industry median. Based on the distribution chart, Lotus Eye Hospital & Institute ranks #308 out of 360 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Lotus Eye Hospital & Institute has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lotus Eye Hospital & Institute's Cyclically Adjusted PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Lotus Eye Hospital & Institute ranks #308 out of 360 companies for Cyclically Adjusted PS Ratio. This places Lotus Eye Hospital & Institute in the lower half of its industry. The industry median Cyclically Adjusted PS Ratio is 1.20. Lotus Eye Hospital & Institute's value of 4.60 is 284.9% above this benchmark. Historically, Lotus Eye Hospital & Institute's own Cyclically Adjusted PS Ratio has ranged from 1.43 to 5.49 over the past decade. While the company's 10-year median is 3.05 vs. the industry median of 1.20, Lotus Eye Hospital & Institute has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Healthcare Providers & Services company?
The median Cyclically Adjusted PS Ratio among Healthcare Providers & Services companies is 1.20, based on 360 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lotus Eye Hospital & Institute's current Cyclically Adjusted PS Ratio of 4.60 is 284.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Lotus Eye Hospital & Institute and its competitors. For the Healthcare Providers & Services industry, the median Cyclically Adjusted PS Ratio is 1.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lotus Eye Hospital & Institute's current Cyclically Adjusted PS Ratio is 4.60, which is 51% above median its own 10-year median of 3.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Eye Hospital & Institute stock overvalued right now?
Based on GuruFocus' analysis, Lotus Eye Hospital & Institute (BOM:532998) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹98.25, compared to a current price of ₹116.45 — trading 18.5% above its estimated fair value. The current Cyclically Adjusted PS Ratio is 4.60, which is 51% above median its 10-year median of 3.05 and 284.9% above the Healthcare Providers & Services industry median of 1.20. Lotus Eye Hospital & Institute's overall GF Score™ is 72/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For Lotus Eye Hospital & Institute (BOM:532998), the current Cyclically Adjusted PS Ratio is 4.60 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lotus Eye Hospital & Institute (BOM:532998) Overvalued in 2026?
Based on GuruFocus' analysis, Lotus Eye Hospital & Institute stock appears to be overvalued.
The current stock price of ₹116.45 is trading 18.5% above its estimated GF Value™ of ₹98.25.
GuruFocus considers Lotus Eye Hospital & Institute to be Modestly Overvalued.
Key valuation signals for BOM:532998:
Cyclically Adjusted PS Ratio: 4.60 (51% above median its 10-year median of 3.05)
GF Value™: ₹98.25 vs. price of ₹116.45 (18.5% above fair value)
Industry Position: 284.9% above the Healthcare Providers & Services median (#308 of 360)
No single metric tells the full story. See the BOM:532998 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lotus Eye Hospital & Institute Ltd is an India-based eye care hospital. It is engaged in providing treatment and care for eye diseases and disorders. It offers treatment services for eye conditions like refractive error, retina and uvea, cornea, glaucoma, pediatric, orbit and oculoplasty, neuro-ophthalmology, and binocular vision. In addition, the company also operates an eye bank for functioning eye donation activities. The company mainly operates in India and generates revenue by providing medical services, pharmacy sales, contact lenses, and optical, of which the majority of the revenue is derived from providing segmmedical services.
72GF Score
Get the complete analysis for BOM:532998
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532998 has been successfully added to your 
